+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Plasma Protein Therapeutics Market - Global Forecast 2025-2030- Product Image
Plasma Protein Therapeutics Market - Global Forecast 2025-2030- Product Image
Sale

Plasma Protein Therapeutics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968904
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The plasma protein therapeutics market is rapidly evolving, marked by advances in biomanufacturing, digital analytics, and collaborative stakeholder engagement. As treatment paradigms and regulatory frameworks shift, senior executives face new opportunities and challenges in scaling access and operational excellence.

Market Snapshot: Plasma Protein Therapeutics Market Size and Growth

The Plasma Protein Therapeutics Market grew from USD 36.19 billion in 2024 to USD 40.49 billion in 2025. It is expected to continue growing at a CAGR of 11.42%, reaching USD 69.27 billion by 2030. Market expansion is underpinned by international efforts to strengthen plasma collection networks, regulatory acceleration of novel therapies, and innovations in analytics that support efficient distribution and real-time supply chain visibility. Sophisticated demand forecasting and modular manufacturing are shaping the competitive landscape, ensuring resilient delivery in dynamic healthcare environments.

Scope & Segmentation

This market research report delivers a granular analysis of the following segments and regions, offering actionable insights for leaders in product development, supply chain, and strategy.

  • Product Categories: Albumin (Five Percent, Twenty Five Percent), Coagulation Factors (Factor IX, Factor VIII, Prothrombin Complex Concentrate), Hyperimmune Globulins (Hepatitis B, Rabies, Tetanus, Varicella Zoster), Immunoglobulins (Intravenous, Subcutaneous)
  • Indication Areas: Cardiovascular, Neurological, Primary Immunodeficiency, Secondary Immunodeficiency, Trauma
  • Route of Administration: Intramuscular, Intravenous, Oral, Subcutaneous
  • End Users: Clinics, Hospitals
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with major markets such as United Kingdom, Germany, France, Russia, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, and more)
  • Leading Companies: CSL Behring LLC, Takeda Pharmaceutical Company Limited, Grifols, S.A., Octapharma AG, Biotest AG, Baxter International Inc., Kedrion S.p.A., LFB S.A., Pfizer Inc., ADMA Biologics

Key segment dynamics are shaped by evolving clinical needs for precision immunomodulation, varied regional healthcare infrastructure, and the adoption of advanced collection and fractionation technologies.

Key Takeaways for Senior Decision-Makers

  • Stakeholder ecosystems are more collaborative, with industry, academic, and health system partners actively addressing supply chain vulnerabilities and patient access barriers.
  • Advancements in fractionation and digital analytics have improved product consistency and accelerated clinical development cycles, supporting new therapy approvals for complex patient populations.
  • Sustainability and ethical sourcing are rising priorities: localized plasma collection models and green manufacturing practices mitigate supply risks and align with global health objectives.
  • Regulatory flexibility, including adaptive approval pathways, helps manufacturers respond to urgent clinical needs and encourages ongoing investment in large-scale registries and post-market surveillance.
  • Regional differentiation compels tailored commercial strategies—successful market entry often depends on local regulatory harmonization, infrastructure maturity, and adaptable distribution networks.

Tariff Impact: Effects of U.S. Measures on Supply Chain Economics

The introduction of new United States tariff measures in 2025 has reshaped cost structures within the plasma protein therapeutics supply chain. Manufacturers are investing in diversified sourcing and exploring alternative distribution hubs to mitigate cost pressures and avoid delays. The tariff adjustments have driven companies to re-examine supply contracts, prioritize high-value therapy segments, and strengthen advocacy for harmonized trade agreements. Proactive firms have reinforced inventory management and supplier relationships, sustaining reliable patient access despite trade policy fluctuations.

Methodology & Data Sources

Analysis is grounded in a robust, multi-layered methodology. The research integrates systematic reviews of peer-reviewed literature, regulatory filings, and technology reports. Industry expert interviews and industry roundtables yielded both quantitative and qualitative intelligence. Triangulation of company disclosures, association statistics, and customs data ensures integrity, while scenario planning adds depth on future market shifts.

Why This Report Matters

  • Empowers executive strategy by mapping high-growth opportunities aligned with evolving clinical needs, regulatory trends, and sustainability imperatives.
  • Informs operational planning through in-depth segmentation analysis and evaluation of tariff impacts, equipping leaders to future-proof their supply chain and portfolio strategy.
  • Delivers actionable competitive intelligence to support business development, investment prioritization, and regional expansion initiatives.

Conclusion

Comprehensive research into the plasma protein therapeutics market equips decision-makers with the tools to anticipate disruption, tailor commercialization, and create sustainable value in a fast-changing healthcare environment. Organizations integrating innovation, adaptability, and stakeholder alignment will realize long-term growth and resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in recombinant plasma protein manufacturing reducing reliance on donor plasma supply
5.2. Increasing adoption of subcutaneous immunoglobulin therapies for primary immunodeficiency patients
5.3. Implementation of novel viral inactivation techniques enhancing safety of fractionated plasma products
5.4. Rising demand for alpha-1 antitrypsin augmentation therapy driven by better diagnostic screening
5.5. Strategic collaborations between biopharma and plasma collection centers to expand hyperimmune globulin portfolios
5.6. Regulatory approvals for next-generation coagulation factors improving treatment options for hemophilia
5.7. Emergence of cell-based expression platforms for monoclonal immunoglobulin production reducing costs
5.8. Supply chain digitalization and cold chain optimization ensuring uninterrupted immunoglobulin availability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Plasma Protein Therapeutics Market, by Product
8.1. Introduction
8.2. Albumin
8.2.1. Five Percent
8.2.2. Twenty Five Percent
8.3. Coagulation Factor
8.3.1. Factor IX
8.3.2. Factor VIII
8.3.3. Prothrombin Complex Concentrate
8.4. Hyperimmune Globulin
8.4.1. Hepatitis B
8.4.2. Rabies
8.4.3. Tetanus
8.4.4. Varicella Zoster
8.5. Immunoglobulin
8.5.1. Intravenous Immunoglobulin
8.5.2. Subcutaneous Immunoglobulin
9. Plasma Protein Therapeutics Market, by Indication
9.1. Introduction
9.2. Cardiovascular
9.3. Neurological
9.4. Primary Immunodeficiency
9.5. Secondary Immunodeficiency
9.6. Trauma
10. Plasma Protein Therapeutics Market, by Route Of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
10.4. Oral
10.5. Subcutaneous
11. Plasma Protein Therapeutics Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
12. Americas Plasma Protein Therapeutics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Plasma Protein Therapeutics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Plasma Protein Therapeutics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. CSL Behring LLC
15.3.2. Takeda Pharmaceutical Company Limited
15.3.3. Grifols, S.A.
15.3.4. Octapharma AG
15.3.5. Biotest AG
15.3.6. Baxter International Inc.
15.3.7. Kedrion S.p.A.
15.3.8. LFB S.A.
15.3.9. Pfizer Inc.
15.3.10. ADMA Biologics
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PLASMA PROTEIN THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PLASMA PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PLASMA PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PLASMA PROTEIN THERAPEUTICS MARKET: RESEARCHAI
FIGURE 24. PLASMA PROTEIN THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. PLASMA PROTEIN THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 26. PLASMA PROTEIN THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PLASMA PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY FIVE PERCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY FIVE PERCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY TWENTY FIVE PERCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY TWENTY FIVE PERCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY FACTOR IX, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY FACTOR VIII, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEPATITIS B, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY RABIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY RABIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY TETANUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY TETANUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY VARICELLA ZOSTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY VARICELLA ZOSTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY TRAUMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 114. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 115. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 116. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 117. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 118. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 119. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 120. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 121. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 122. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 123. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 130. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 131. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 132. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 133. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 134. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 135. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 136. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 137. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 138. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 139. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 214. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 215. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 216. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 217. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 218. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 219. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 220. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 221. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 228. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 229. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 230. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 231. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 232. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 233. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 234. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 235. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 236. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 237. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 262. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 263. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 264. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 265. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 266. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 267. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 268. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 269. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 276. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 277. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 278. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 279. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 280. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 281. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 282. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 283. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 284. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 285. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTOR, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULIN, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

  • CSL Behring LLC
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • Octapharma AG
  • Biotest AG
  • Baxter International Inc.
  • Kedrion S.p.A.
  • LFB S.A.
  • Pfizer Inc.
  • ADMA Biologics

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 40.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 69.27 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Plasma Protein Therapeutics - Global Strategic Business Report - Product Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Plasma Protein Therapeutics Market Report 2025 - Product Image

Plasma Protein Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Plasma Protein Therapeutics Market Report and Forecast 2025-2034 - Product Image

Plasma Protein Therapeutics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Plasma Protein Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Plasma Protein Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 96 Pages
  • Global
From
Protein Therapeutics Market - Global Forecast 2025-2030 - Product Image

Protein Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From

About the Plasma Protein Drug Market

The Plasma Protein Drug market is a subset of the biopharmaceutical industry, focusing on the development and production of drugs derived from human plasma proteins. These drugs are used to treat a variety of conditions, including immune deficiencies, bleeding disorders, and other rare diseases. Plasma protein drugs are typically produced through fractionation, a process that separates the proteins from the plasma. This process is used to create a variety of products, including albumin, immunoglobulins, and clotting factors. The Plasma Protein Drug market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products. Additionally, the market is highly competitive, with a number of companies vying for market share. Some of the major players in the Plasma Protein Drug market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.